Skip to content
Review Open access

Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic–metabolic axis with natural compounds and emerging therapies

Oct 2026 · Frontiers in Cell and Developmental Biology · Vol 14 · 0 citations · 161 references
Medicine

TL;DR

The concept of the adaptive methylation landscape is proposed, a perturbation-responsive, state-associated, and potentially reversible distribution of methylation states that contributes to shaping the spectrum of cellular states accessible during tumor evolution.

Abstract

Cancer cell plasticity enables tumor cells to dynamically transition between diverse phenotypic states, including epithelial–mesenchymal plasticity stemness, dormancy, lineage switching, immune evasion, and therapy-resistant phenotypes. Although metabolic reprogramming and epigenetic regulation have each been recognized as hallmarks of cancer, the mechanistic framework linking metabolic adaptation to dynamic cell-state transitions remains incompletely understood. In this Review, we propose that methylation serves as a major mechanistic interface through which metabolic rewiring can influence adaptive cancer cell plasticity. We discuss how one-carbon metabolism regulates the availability of the universal methyl donor S-adenosylmethionine (SAM), thereby influencing DNA methylation, histone methylation, and multiple forms of RNA methylation, with N6-methyladenosine (m6A) representing the principal RNA modification discussed in this review. Rather than responding uniformly to metabolic change, these methylation systems represent distinct but metabolically connected regulatory layers that share dependence on one-carbon metabolism while differing in their biochemical sensitivities and regulatory outputs. Net methylation states, however, are also shaped by metabolically constrained demethylation, including α-ketoglutarate-, oxygen-, Fe2+-, and flavin adenine dinucleotide (FAD)-dependent eraser pathways. Together, these metabolically responsive writing and erasing processes influence transcriptional stability, chromatin accessibility, and post-transcriptional regulation during reversible cell-state transitions. We further examine how environmental and therapeutic stresses, including hypoxia, nutrient limitation, immune surveillance, and anticancer therapy, reshape methylation programs through metabolic adaptation, and how such remodeling may support phenotypic flexibility and survival under selective pressure. Building upon these advances, we propose the concept of the adaptive methylation landscape, a perturbation-responsive, state-associated, and potentially reversible distribution of methylation states that contributes to shaping the spectrum of cellular states accessible during tumor evolution. Finally, we discuss emerging therapeutic strategies targeting the metabolic-methylation axis and highlight how single-cell multi-omics, spatial epigenomics, functional epigenome editing, and AI may enable dynamic mapping of adaptive methylation landscapes. We propose that cancer cell plasticity is not merely a genetic phenomenon but can also be shaped by metabolically responsive methylation programs, providing a testable conceptual framework for future precision epigenetic therapies.

Read PDF

Similar papers

Editorial Open access Oct 2026

Epigenetics in cancer: from mechanisms to precision medicine

This Thematic Issue on Epigenetics in Cancer brings together leading experts to review recent conceptual and technological advances that are reshaping the field and highlights how fundamental discoveries are driving translational innovation and precision oncology.

Sung Hee Baek · 0 citations
Review Oct 2026

Hypoxia-induced epigenetic reprogramming of cancer stem cells: Linking stemness, metastasis, and therapy resistance.

Hypoxia is a defining feature of the solid tumor microenvironment and a central driver of cancer-stem-cell (CSC) biology, yet the epigenetic mechanisms linking oxygen deprivation to stemness, metastasis, and therapy resistance remain fragmented across the literature. This review synthesizes that evidence into a unified...

M. Al-khreisat, Rustam Narzikulov, O. Allela et al. · 0 citations
Review Open access Oct 2026

Lung cancer metabolism: a dynamic and adaptive network

This review presents lung cancer metabolism as an integrated and adaptable system rather than a collection of isolated pathways, and identifies metabolic dependencies that may be leveraged for therapeutic intervention.

Sara Gholamhosseinian Najjar, C. Frezza · 0 citations
Review Open access Sep 2026

The Crosstalk Between Metabolic Reprogramming and Histone Methylation in Tumor Immunity and Immunotherapy

Histone methylation regulates chromatin structure and gene expression, whereas tumor metabolism provides bioenergetic and biosynthetic inputs. These processes are bidirectionally linked: S-adenosylmethionine supplies methyl groups for histone methyltransferases, α-ketoglutarate(α-KG) supports JmjC-domain demethylases,...

Jia-Yao Dou, Rui-Cheng Xue, Wei Gao et al. · 0 citations
Review Open access Sep 2026

The Epigenetic Aging–Cancer Continuum: Biomarkers, Metabolism, and Therapy

The epigenetic aging–cancer link, how nutrition and metabolism modify pathways, and the potential of circulating biomarkers for diagnosis, prognosis, prediction, and monitoring are explored.

C. Papaneophytou, M. Pieri, Maria-Eleni Makreli et al. · 0 citations
Review Open access Oct 2026

Genes, fuel, and fate in lung cancer

Abstract Cellular plasticity is a central feature of malignant progression, allowing tumour cells to change identity during tumour evolution, therapeutic adaptation, and metastatic dissemination. This issue is especially acute in lung cancer, where the respiratory epithelium is intrinsically permissive to cell-state ch...

Julia S. Scott, C. Lutz, S. Preković · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.